• Home
  • Clinical Topics
    • Cardiovascular Disease
    • Diabetes
    • Hematology
    • Infectious disease
    • Mental health / PTSD
    • Neurology
    • Oncology
    • Orthopedics
    • Pain management
    • Pulmonology
    • Rheumatology
    • Women’s health
  • Non-Clinical Topics
    • Legislation
    • Personnel
    • Policy
    • Research
    • Pharmacy Update
    • Technology
  • Special Issues
    • 2025 USM Directory
    • Advances in Treatment for Diffuse Large B-Cell Lymphoma
    • Advances in Treatment of Metastatic Colorectal Cancer
    • Advances in Treatment for Small Cell Lung Cancer
    • 2024 Compendium of Federal Medicine
  • Departments
    • Department of Veterans Affairs (VA)
    • Military Health System
    • Public Health Service
  • Opinion
  • Subscription
    • Print Subscription
    • e-Newsletter Subscription
  • Contact Us

Difficult Decision: When Should Suppressive Antibiotic Therapy Be Used for VA Patients With Prosthetic-Joint Infections?

by LaTina Emerson | May 12, 2025

Clinical decisions in the VA about whether to administer suppressive antibiotic therapy for patients with prosthetic-joint infections are often emotionally charged due to limited evidence about benefits and risks and potential consequences such as reinfection or amputation, according to a recent study.

Deaths From Bacterial Bloodstream Infections Significant in MHS Patients

by LaTina Emerson | Apr 8, 2025

The mortality burden associated with bacterial bloodstream infections is substantial in the MHS, with about 1 in 4 patients dying within 1 year of a bacterial bloodstream infection diagnosis, according to a recent study.

2023-to-2024 XBB.1.5 COVID-19 Vaccines Weren’t Effective Over Long Term

by Brenda Mooney | Mar 17, 2025

Serious concerns were raised in a new VA study about the effectiveness of COVID-19 vaccines targeting the XBB.1.5 Omicron variant, which were introduced in September 2023.

High Plantar Fasciopathy Rates in U.S. Military

by U.S. Medicine | Mar 17, 2025

U. S. armed forces have high rates of ankle and foot injuries and mean medical and personnel costs for the DoD.

Concerns Raised About Severe Allergic Reactions in Outdoor Military Personnel

by LaTina Emerson | Feb 11, 2025

Tick bites in U.S. military personnel are leading to the development of antibodies to alpha-gal, a molecule found in most mammals, and possibly alpha-gal syndrome, a serious, potentially life-threatening allergic reaction.

Melatonin Appears to Have Some Effect Enhancing Flu Vaccine

by U.S. Medicine | Jan 8, 2025

Noting that vaccine immunogenicity is affected by a variety of factors, melatonin has been reported to affect immune responses to vaccines and infection, according to a new study.

Older White Veterans Most Likely to Get Flu Vaccines

by U.S. Medicine | Jan 8, 2025

How do race, ethnicity, sex and rurality affect influenza vaccination adherence in a VHA cohort?

House Coronavirus Committee Held Its Last Meeting in November

House Coronavirus Committee Held Its Last Meeting in November

by Stephen Spotswood | Dec 11, 2024

Next month marks the 5-year anniversary of the first case of COVID-19 reported in the United States. Since then, more than 110 million Americans have been infected, and 1.2 million have died.

Federal Medicine’s Role in Uncovering How the Epstein-Barr Virus Relates to MS

by Annette Boyle | Dec 10, 2024

We interviewed Lynn Levin, MD, formerly of the Department of Epidemiology, Division of Preventive Medicine, Walter Reed Army Institute of Research, about the research that led to the discovery of the crucial role of the Epstein-Barr virus in the development of multiple sclerosis and several other autoimmune disorders.

DHA Releases Flyer to Educate Servicemembers About Mpox Risk, Protection

by Mary Anne Dunkin | Nov 8, 2024

In response to the August 2024 upsurge of mpox in the Democratic Republic of Congo and other Africa countries, the Defense Health Agency (DHA) has produced a new flyer: Mpox—What Servicemembers SHOULD KNOW.

More Point-of-Care Testing in Military Could Help Curb STI Transmissions

More Point-of-Care Testing in Military Could Help Curb STI Transmissions

by Mary Anne Dunkin | Oct 14, 2024

Sexually transmitted infections (STIs) affect an estimated 1 in 5 servicemembers, making early diagnosis and treatment important for controlling their spread among this high-risk population.

New Study Warns About Increased Antibiotic Resistance Against Third-Generation Broad-Spectrum Antibiotics in VA Facilities

New Study Warns About Increased Antibiotic Resistance Against Third-Generation Broad-Spectrum Antibiotics in VA Facilities

by LaTina Emerson | Oct 14, 2024

VHA facilities across the United States have experienced a concerning rise in antibiotic resistance to third-generation cephalosporins, a class of broad-spectrum antibiotics commonly used to treat the Enterobacterales bacterial species.

Unraveling the Mystery of Long COVID: VA Steps Up for Nation in Crisis

by Annette Boyle | Sep 16, 2024

By March 2020, the SARS-COV-2 virus had reached every inhabited continent on the globe, with devastating impact. In response, the U.S. and many other countries entered lockdowns to slow the spread and reduce deaths from the virus.

RSV Is as Severe as COVID-19, Flu When Everyone’s Unvaccinated

by U.S. Medicine | Jun 20, 2024

A recent study suggested that RSV disease severity is similar to unvaccinated patients hospitalized with COVID-19 or influenza, but significantly more severe than patients hospitalized with those diseases who had been vaccinated.

Mounting Evidence of RSV Severity Bolsters Argument for Vaccination

by Brenda Mooney | Jun 20, 2024

Immunization levels against respiratory syncytial virus (RSV) among older adults remained relatively low at around 24% as of late March. As a comparison, national coverage with influenza vaccines for all U.S. adults was 48.3% in the same time period, 2% higher than last year.

Mortality Up in VHA Inpatients With COVID-19 Plus Hospital-Acquired Infections

by Mary Anne Dunkin | Jun 19, 2024

Pseudomonas aeruginosa (PA), an opportunistic pathogen commonly associated with healthcare-associated infections, has a high mortality rate. The organism’s high virulence and ability to rapidly acquire resistance to antibiotics make PA infections a treatment challenge.

Nearly 20% of Veterans Showed Decline During COVID-19 Pandemic

by U.S. Medicine | Jun 19, 2024

While most U.S. veterans maintained or improved physical and mental function a year into the COVID-19 pandemic, almost 20% showed a decline, according to a new study.

HIV Preexposure Prophylaxis in MHS Not Linked to Higher STI Risk

by Mary Anne Dunkin | Feb 15, 2024

Consistent use of HIV preexposure prophylaxis (PrEP) has been shown to reduce the risk of sexual risk of HIV acquisition by 99% among men who have sex with men (MSM).

VA Study: Microbial Contamination Continues in Hospitals, Even When Recommended Cleaning Protocols Are Followed

by Brenda Mooney | Feb 15, 2024

Microbial contamination—including pathogenic and potentially pathogenic bacteria—persisted on high-touch hospital surfaces despite compliance with recommended disinfection protocols, according to a study performed at the Central Texas Veterans Healthcare System.

COVID-19 Mortality Looks Somewhat Different Based on New VA Study

by Brenda Mooney | Nov 13, 2023

A study team involving VA researchers looked at death rates during the COVID-19 pandemic through a different lens and came up with intriguing information from individual-level instead of aggregate data.

Military/VA Study Finds That Smallpox Vaccination Is Effective Against MPox

by LaTina Emerson | Nov 13, 2023

The smallpox vaccine appeared to be effective in preventing mpox (formerly called monkeypox) in U.S. military personnel and veterans, even if received more than a decade previously, according to a new report.

Too Few VA Anal Cancer Exams in HIV Patients

by U.S. Medicine | Oct 14, 2023

Because human immunodeficiency virus (HIV) patients are at high risk for anal cancer, screenings are recommended annually for U.S. veterans with HIV.

Flexible Prevention Bundle Appears to Reduce Some Surgical Site Infections

by Mary Anne Dunkin | Sep 21, 2023

Surgical site infections (SSIs) are associated with significant morbidity and mortality, prolonged length of hospital stay and readmission.

Lower Risks of Adverse Effects in Older Adults With Moderna COVID-19 Vaccine

by Brenda Mooney | Sep 21, 2023

Receipt of the Moderna COVID-19 vaccine by older adults was associated with a lower risk of adverse events than the Pfizer-BioNTech version, according to a new study.

Antibiotic Prescribing High for Respiratory Infection Patients; HIV Not a Factor

by LaTina Emerson | Sep 19, 2023

Inappropriate antibiotic prescribing for acute respiratory infections, a major public health concern, is high in both patients with and without human immunodeficiency virus (HIV) and doesn’t appear to be affected by HIV status, according to a recent study.

VA Doctor-Turned-Inventor Works to Prevent Infectious Disease Spread

by Stephen Spotswood | Aug 17, 2023

Part of the inspiration for Chetan Jinadatha, MD, MPH, to specialize in treating infectious disease comes from going to medical school in his native India, which has a high burden of such diseases. However, he also likes to say it’s partly for selfish reasons.

VA Researchers Find Biomarkers for Potentially Serious Parasitic Infections

VA Researchers Find Biomarkers for Potentially Serious Parasitic Infections

by U.S. Medicine | Jul 13, 2023

Asymptomatic Leishmaniasis Infected Nearly 20% of Soldiers in Iraq BETHESDA, MD—New research has identified three chemokines as potential biomarkers for asymptomatic visceral leishmaniasis (VL), a chronic infection caused by Leishmania (L.) donovani or L. infantum....

Do Fungal Pathogens Cause ARI More Often Than Previously Suspected?

by Mary Anne Dunkin | Jun 13, 2023

Fungal infections are known to be causes of community-acquired pneumonia (CAP) and acute respiratory illness (ARI), but it is not clear how their frequency compares with that of viral and bacterial causes of these conditions.

Paxlovid Reduces Likelihood of Long COVID in Patients at Severe Infection Risk

by Brenda Mooney | Jun 13, 2023

A recent study suggested, that Paxlovid, which is prescribed to patients infected with SARS-CoV-2, who are at risk for severe symptoms, also might help protect against the condition. Researchers found the antiviral also lowered the likelihood of post-acute death and hospitalization.

VA Spent Millions on HPV-Related Cancer But No Vaccination Promotion

by U.S. Medicine | Apr 17, 2023

Vaccinations for Veterans, Servicemembers Half of Civilian Rate ST. LOUIS—Eligible active-duty servicemembers and veterans have dramatically lower rates of human papillomavirus (HPV) vaccination, placing them at much greater risk of related cancers, according to a new...

Subscribe to the print edition of U.S. Medicine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and Indian Health Service.

Subscribe Now

Sign up to receive the U.S. Medicine e-Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

 Sign Up

  • For Advertisers
  • e-Newsletter
  • Subscribe to U.S. Medicine Print Publication
  • About Us
  • Privacy Policy